Defence Therapeutics Advances Precision Radiopharmaceutical Development with CNL
Defence Therapeutics Inc., a publicly traded biotechnology company focused on precision intracellular drug delivery, has announced an expansion of its long-standing collaboration with Canadian Nuclear Laboratories (CNL) to accelerate the development of its radiopharmaceutical pipeline.
Precision Radiopharmaceutical | 30/01/2026 | By Darshana
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy